Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Interventional Cardiology Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Interventional Cardiology Market, India
2.1 Interventional Cardiology Market, India, Revenue ($m), 2024-2036
2.1.1 Coronary Stents Market, India, Revenue ($m), by Segment, 2024-2036
2.1.2 Intravascular Ultrasound Systems (IVUS) Market, India, Revenue ($m), by Segment, 2024-2036
2.1.3 PTCA Balloon Catheters Market, India, Revenue ($m), by Segment, 2024-2036
2.1.4 Structural Heart Occlusion Devices Market, India, Revenue ($m), by Segment, 2024-2036
2.1.5 Transcatheter Accessories Market, India, Revenue ($m), by Segment, 2024-2036
2.2 Interventional Cardiology Market, India, Volume (Units), 2024-2036
2.2.1 Coronary Stents Market, India, Volume (Units), by Segment, 2024-2036
2.2.2 Intravascular Ultrasound Systems (IVUS) Market, India, Volume (Units), by Segment, 2024-2036
2.2.3 PTCA Balloon Catheters Market, India, Volume (Units), by Segment, 2024-2036
2.2.4 Structural Heart Occlusion Devices Market, India, Volume (Units), by Segment, 2024-2036
2.2.5 Transcatheter Accessories Market, India, Volume (Units), by Segment, 2024-2036
2.3 Interventional Cardiology Market, India, Average Price ($), 2024-2036
2.4 Interventional Cardiology Market, India, Company Share by Revenue ($m), 2025
3 Interventional Cardiology Market Pipeline Products
3.1 Interventional Cardiology Market Pipeline Products
3.2 Interventional Cardiology – Pipeline Products by Stage of Development
3.3 Interventional Cardiology – Pipeline Products by Segment
3.4 Interventional Cardiology – Pipeline Products by Territory
3.5 Interventional Cardiology – Pipeline Products by Regulatory Path
3.6 Interventional Cardiology – Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in India, Interventional Cardiology Market
4.1 Boston Scientific Corp
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Shockwave Medical Inc
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Koninklijke Philips NV
4.5.1 Company Overview
4.6 B. Braun Melsungen AG
4.6.1 Company Overview
4.7 Terumo Corp
4.7.1 Company Overview
4.8 Biotronik SE & Co KG
4.8.1 Company Overview
4.9 Asahi Intecc Co Ltd
4.9.1 Company Overview
4.10 Lepu Medical Technology (Beijing) Co Ltd
4.10.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Mar 10, 2026: Butterfly Network Appoints David Horsley as Senior Vice President of Innovation, Butterfly Embedded
5.1.2 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
5.2 Government and Public Interest
5.2.1 Oct 27, 2025: Kymera Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
5.3 Other Significant Developments
5.3.1 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
5.3.2 Oct 05, 2025: UAB Medicine Successfully Implants Two TransForm McCarthy Mitral Annuloplasty Rings
5.3.3 Sep 23, 2025: American Medical Association Publishes CPT Code for Caristo's Coronary Inflammation Detection Technology
5.4 Product News
5.4.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
5.4.2 Nov 19, 2025: BeGraft Plus CE-Approved for Use as BEVAR Bridging Stent
5.4.3 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
5.4.4 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
5.4.5 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
5.4.6 Oct 22, 2025: Hospital Del Mar Participates In Study To Modify Pharmacological Treatment After Angioplasty
5.4.7 Oct 21, 2025: SpectraWAVE Receives 510(k) Clearance for X1-FFR, an AI-Enabled, Wire-Free, Drug-Free Physiology Solution
5.4.8 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
5.4.9 Oct 13, 2025: Getinge’s Advanta V12 Receives CE Mark for Major Bridging Indications
5.4.10 Oct 05, 2025: UAB Medicine Successfully Implants Two TransForm McCarthy Mitral Annuloplasty Rings
5.4.11 Sep 23, 2025: American Medical Association Publishes CPT Code for Caristo's Coronary Inflammation Detection Technology
5.5 Strategy And Business Planning
5.5.1 Nov 20, 2025: New Propelus Prototype Centers
5.5.2 Nov 13, 2025: Teijin And URAT Partner To Expand Regenerative Medicine And Implantable Medical Devices In Japan And India
5.5.3 Oct 27, 2025: Remedy Robotics And Mission Thrombectomy Partner To Expand Access To Thrombectomy For Stroke
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 GlobalData Consulting
6.3 Contact Us
6.4 Disclaimer